Blood Cancer UK: Transformational Research Awards

Overview

Remit

Grants will typically be awarded for up to five years and for a maximum of £1,000,000.

This scheme is designed to support:

• Advanced/late-stage pre-clinical research.
• Clinical and experimental medicine (including clinical studies or trials).
• Research to accelerate the uptake of new treatments and other interventions into the NHS.

Applications for smaller-scale discovery science, translational, or clinical projects should be submitted to the charity’s annual Project Grants scheme.

Applications for innovative, large-scale clinical trials testing multiple interventions that are adaptable in design should be submitted to Blood Cancer UK’s new large-scale clinical trial funding scheme.

All applicants for the charity’s Transformational Research Awards scheme, including those applying for funding for advanced/late-stage pre-clinical research, must clearly outline the specific transformational change they are aiming to make progress towards through their proposed research and how this change could be transformational for the blood cancer/precursor population/s of interest.

All applicants must also clearly describe how the proposed research will accelerate progress towards the desired change for people with or at risk of developing blood cancer, including:

• the progress towards the identified transformational change for people with or at risk of blood cancer that will be made during the research itself.
• the immediate next steps that would be required (e.g., a phase I clinical trial).
• the overall pathway to clinical uptake into the NHS or wider UK health system and to real-world impact for patients.

Blood Cancer UK expects meaningful Patient and Public Involvement (PPI) to be embedded in all research funded through this scheme. The proposed research should also be inclusive by design and have an inclusive recruitment strategy in place to ensure people are recruited who are representative of the disease group/subgroups under investigation.

Eligibility

Individuals based at UK universities, hospitals or other recognised research institutions who are able to sign up to Blood Cancer UK’s Terms and Conditions are eligible to apply.